{"id":"W2804327225","doi":"10.1200/jco.2017.35.15_suppl.tps3629","title":"NRG-GI002: A phase II clinical trial platform for total neoadjuvant therapy (TNT) in rectal cancer.","year":2017,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Capecitabine; Colorectal cancer; Neoadjuvant therapy; Clinical endpoint; Total mesorectal excision; Oncology; Population; FOLFOX; Internal medicine; Chemoradiotherapy; Randomized controlled trial; Radiation therapy; Cancer; Surgery; Oxaliplatin; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004476824,0.001367519,0.001003895,0.0005568253,0.000329614,0.0009676532,0.001183116,0.001527742,0.008804257],"category_scores_gemma":[0.002012868,0.0004856111,0.00103404,0.0005829661,0.001044196,0.0006977345,0.000855469,0.002667018,0.001755226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007271937,"about_ca_system_score_gemma":0.003677546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007694044,"about_ca_topic_score_gemma":0.002794245,"domain_scores_codex":[0.9991058,0.0005724906,0.00002970723,0.00009331945,0.00009575574,0.0001029948],"domain_scores_gemma":[0.9990383,0.0001329083,0.0002372988,0.0001165337,0.00006269045,0.0004122965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6620292,0.05282122,0.004851122,0.002573889,0.0008694216,0.0003402669,0.00032622,0.004758949,0.06971434,0.002082239,0.02702816,0.172605],"study_design_scores_gemma":[0.6914451,0.2873203,0.004551102,0.0001216383,0.0002426956,0.0003152333,0.00004669057,0.001698814,0.003141367,0.0006773034,0.01040587,0.00003397913],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.9025704,0.005420725,0.007268607,0.004731201,0.0008650711,0.0529462,0.01188422,0.001432901,0.01288076],"genre_scores_gemma":[0.8241619,0.004563062,0.03534288,0.006465319,0.0005066727,0.09298124,0.01815022,0.0003027055,0.01752607],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.008804257,"threshold_uncertainty_score":0.02945322,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4128762817880377,"score_gpt":0.611146713313172,"score_spread":0.1982704315251343,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}